Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial

Gary Raskob; Nick van Es; Annelise Segers; Pantep Angchaisuksiri; Doyeun Oh; Zoltán Boda; Roger Lyons; Karina Meijer; Ivan Gudz; Jeffrey Weitz; George Zhang; Hans Lanz; Michele Mercuri; Harry Büller; Dominique Mottier

Journal articles

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial

Gary Raskob Nick van Es Annelise Segers Pantep Angchaisuksiri Doyeun Oh Zoltán Boda ¹ Roger Lyons Karina Meijer ² Ivan Gudz Jeffrey Weitz ³ George Zhang Hans Lanz Michele Mercuri Harry Büller Dominique Mottier ^{4, 5}

1 DEBRECEN - Dpt Medicine - Department of Medicine

2 Haematology

3 McMaster University [Hamilton, Ontario]

4 GETBO - Groupe d'Etude de la Thrombose de Bretagne Occidentale

5 CIC Brest

Document type :

Journal articles

Domain :

Life Sciences [q-bio]

Life Sciences [q-bio] / Human health and pathology

Life Sciences [q-bio] / Human health and pathology / Cardiology and cardiovascular system

Complete list of metadata

https://hal.univ-brest.fr/hal-02043621
Contributor : Ghislaine Calvez Connect in order to contact the contributor
Submitted on : Thursday, February 21, 2019 - 10:23:04 AM
Last modification on : Friday, August 5, 2022 - 2:30:05 PM

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial

Identifiers

Collections

Citation

Export

Metrics

31

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial

Identifiers

Collections

Citation

Export

Share

Metrics

31